# Exhaled NO as a Biomarker of Gestational OSA and Persistence Postpartum

> **NCT02100943** · — · COMPLETED · sponsor: **Wake Forest University Health Sciences** · enrollment: 76 (actual)

## Conditions studied

- Pregnancy
- OSA

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02100943
- **Lead sponsor:** Wake Forest University Health Sciences
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2014-03
- **Primary completion:** 2016-11-14
- **Final completion:** 2016-11-14
- **Target enrollment:** 76 (ACTUAL)
- **Last updated:** 2017-04-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02100943

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02100943, "Exhaled NO as a Biomarker of Gestational OSA and Persistence Postpartum". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT02100943. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
